Therini Bio, Inc. — Form D/A
Therini Bio, Inc. of SACRAMENTO, CA, a company, filed a Form D amendment with the SEC on 2025-09-08. The offering totals $80.8M, of which $74.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-09-08
- Form: D/A
- Accession: 0001776935-25-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $80.8M
- Amount sold: $74.9M
- Remaining: $5.9M
- Investors: 17
- Date of first sale: 2023-03-29
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-478843
Issuer
- Name: Therini Bio, Inc.
- CIK: 0001776935
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 2108 N STREET, SACRAMENTO, CA, 95816
- Phone: (818) 414-1105
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Laurence Barker | Director | BOSTON, MA |
| Daniel D Burgess | Director | Sacramento, CA |
| Laia D Crespo-Martin | Director | Sacramento, CA |
| Olga D Danilchanka | Director | Sacramento, CA |
| Tara Nickerson | Director | Sacramento, CA |
| Michael D Ross | Director | Sacramento, CA |
| Tara Nickerson | Executive Officer | Sacramento, CA |
| Leslie D Schulze | Executive Officer | Sacramento, CA |
| Michael Ross | Director | South San Francisco, CA |
| Houman D Ashrafian | Director | Sacramento, CA |
| Jeffrey D Stavenhagen | Executive Officer | Sacramento, CA |
| Michael Quigley | Director | Sacramento, CA |
| Michael Quigley | Executive Officer | Sacramento, CA |
| David D Dolby | Director | Sacramento, CA |
| Tracy Saxton | Director | Kingston, RI |
| Aikaterini Akasoglou | Director | SOUTH SAN FRANCISCO, CA |
| Leslie Schulze | Executive Officer | South San Francisco, CA |
| Jeffrey Stavenhagen, Ph.D. | Executive Officer | South San Francisco, CA |
| Daniel Burgess | Director | NESS ZIONA, L3 |
| Daniel Burgess | Executive Officer | NESS ZIONA, L3 |
| Edward Spack | Executive Officer | SAN FRANCISCO, CA |
Other filings by this issuer (3)
More